JP2009137992A5 - - Google Patents

Download PDF

Info

Publication number
JP2009137992A5
JP2009137992A5 JP2009004309A JP2009004309A JP2009137992A5 JP 2009137992 A5 JP2009137992 A5 JP 2009137992A5 JP 2009004309 A JP2009004309 A JP 2009004309A JP 2009004309 A JP2009004309 A JP 2009004309A JP 2009137992 A5 JP2009137992 A5 JP 2009137992A5
Authority
JP
Japan
Prior art keywords
peptide
column
concentration
peptides
toxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009004309A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009137992A (ja
JP4484941B2 (ja
Filing date
Publication date
Priority claimed from US09/820,053 external-priority patent/US6875744B2/en
Application filed filed Critical
Publication of JP2009137992A publication Critical patent/JP2009137992A/ja
Publication of JP2009137992A5 publication Critical patent/JP2009137992A5/ja
Application granted granted Critical
Publication of JP4484941B2 publication Critical patent/JP4484941B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2009004309A 2001-03-28 2009-01-13 生物活性を有する短ペプチド及び該ペプチドの使用方法 Expired - Lifetime JP4484941B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27950501P 2001-03-28 2001-03-28
US09/820,053 US6875744B2 (en) 2001-03-28 2001-03-28 Short bioactive peptides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002578411A Division JP4310107B2 (ja) 2001-03-28 2002-03-28 生物活性を有する短ペプチド及び該ペプチドの使用方法

Publications (3)

Publication Number Publication Date
JP2009137992A JP2009137992A (ja) 2009-06-25
JP2009137992A5 true JP2009137992A5 (cg-RX-API-DMAC7.html) 2010-04-02
JP4484941B2 JP4484941B2 (ja) 2010-06-16

Family

ID=26959709

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002578411A Expired - Lifetime JP4310107B2 (ja) 2001-03-28 2002-03-28 生物活性を有する短ペプチド及び該ペプチドの使用方法
JP2009004309A Expired - Lifetime JP4484941B2 (ja) 2001-03-28 2009-01-13 生物活性を有する短ペプチド及び該ペプチドの使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002578411A Expired - Lifetime JP4310107B2 (ja) 2001-03-28 2002-03-28 生物活性を有する短ペプチド及び該ペプチドの使用方法

Country Status (8)

Country Link
US (1) US7381704B2 (cg-RX-API-DMAC7.html)
EP (2) EP1379265A4 (cg-RX-API-DMAC7.html)
JP (2) JP4310107B2 (cg-RX-API-DMAC7.html)
KR (1) KR100891157B1 (cg-RX-API-DMAC7.html)
AU (1) AU2002255952A1 (cg-RX-API-DMAC7.html)
CA (1) CA2441562C (cg-RX-API-DMAC7.html)
ES (1) ES2389285T3 (cg-RX-API-DMAC7.html)
WO (1) WO2002079408A2 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004229465B2 (en) * 2003-04-09 2010-04-29 The United States Of America Department Of Veterans Affairs Compositions and methods related to production of erythropoietin
JP2005281225A (ja) * 2004-03-30 2005-10-13 Japan Science & Technology Agency 新規塩基性抗菌ペプチド及びその利用
AU2006272483A1 (en) * 2005-07-27 2007-02-01 Marina Biotech, Inc. Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents
US7601361B2 (en) * 2005-10-03 2009-10-13 E. I. Du Pont De Nemours And Company Process for providing antimicrobial surfaces
CA2638823A1 (en) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
KR101552453B1 (ko) * 2006-06-01 2015-09-11 데라퓨틱 펩타이즈, 인코포레이션 중합성 생계면활성제
PT2402369E (pt) 2006-06-13 2016-02-19 Helix Biomedix Inc Fragmentos peptídicos para induzir a síntese de proteínas da matriz extracelular
KR100742982B1 (ko) * 2006-06-22 2007-07-26 케이맥(주) 초점 타원계측기
CN101679495B (zh) * 2007-01-05 2013-07-17 赫里克斯生物医疗公司 用于细胞学和免疫学调节的短的生物活性肽
AU2008243720B2 (en) * 2007-05-01 2012-07-05 Biolab Sanus Farmaceutica Ltda. Analgesic compounds
EP2205623B1 (en) 2007-10-29 2016-03-16 Helix Biomedix Inc. Protective skin care tetrapeptides
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
EP2168591A1 (en) * 2008-09-24 2010-03-31 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Antimicrobial peptides
US20120270770A1 (en) * 2010-08-03 2012-10-25 Jesse Michael Jaynes Anti-angiogenic peptides and their uses
MX2015000863A (es) 2012-07-19 2016-05-05 Alethia Biotherapeutics Inc Anticuerpos anti-siglec-15.
ITBS20120126A1 (it) 2012-08-01 2014-02-02 Paoli Ambrosi Gianfranco De Composizione antibatterica per uso topico
JP2016518352A (ja) * 2013-04-09 2016-06-23 モヘイ エルディン エラウダン，カーレド 悪性腫瘍のコントロールにおける単剤治療としての新規ペプチド
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
BR112017007543A2 (pt) 2014-10-14 2017-12-19 Riptide Bioscience Inc peptídeos com propriedades anti-inflamatórias
CN105061562B (zh) * 2015-09-16 2018-01-12 山东电力中心医院 一种具有抗肺癌作用的寡肽及其应用
US9439917B1 (en) * 2015-12-28 2016-09-13 Shetal Amit Shah Anti-blepharitis compositions and their use
CA3014442A1 (en) 2016-02-29 2017-09-08 Dana-Farber Cancer Institute, Inc. Stapled intracellular-targeting antimicrobial peptides to treat infection
WO2019018499A2 (en) * 2017-07-19 2019-01-24 Dana-Farber Cancer Institute, Inc. ANTIMICROBIAL PEPTIDES STABILIZED FOR THE TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIAL INFECTIONS
BR112020017397A2 (pt) * 2018-04-30 2021-01-19 L'oreal Peptídeo, composição para inibir a contração de células musculares, método para inibir a contração de células musculares, método para induzir a proliferação de células epidérmicas e método para reduzir a aparência de rugas
FR3099060B1 (fr) * 2019-07-26 2022-01-14 Bionuclei Complexe hybride mineral et organique et son utilisation pour le maintien de l’equilibre microbiologique de la peau et/ou d’une composition cosmetique et/ou dermopharmaceutique
WO2025122089A1 (en) * 2023-12-06 2025-06-12 Karadeni̇z Tekni̇k Uni̇versi̇tesi̇ Teknoloji̇ Transferi̇ Uygulama Ve Arasti̇rma Merkezi̇ Development of a novel chitosan conjugated antimicrobial peptide as an alternative to antibiotics
WO2025157595A2 (en) * 2024-01-25 2025-07-31 Lipotrue, S.L. Peptides and cosmetic compositions for use in the treatment of acne and its related skin conditions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520016A (en) * 1980-06-17 1985-05-28 Kabigen Ab Bacteriolytic proteins
US4355104A (en) * 1980-06-17 1982-10-19 Kabigen Ab Bacteriolytic proteins
CA1327311C (en) * 1987-07-06 1994-03-01 Jesse M. Jaynes Therapeutic antimicrobial polypeptides, their use and methods for preparation
DE3854476T2 (de) 1987-07-06 1996-04-04 Univ Louisiana State Inhibierung von eukaryotischen pathogenen und neoplasmen mit lytischen peptiden.
US5861478A (en) * 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
AU5433190A (en) * 1989-04-10 1990-11-16 Louisiana State University And Agricultural And Mechanical College Lytic peptides, use for growth, infection and cancer
AU654714B2 (en) * 1991-04-08 1994-11-17 Magainin Pharmaceuticals, Inc. Novel peptide compositions and uses therefor
US5955573A (en) 1993-06-04 1999-09-21 Demegen, Inc. Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same
US5561107A (en) * 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
AU7050294A (en) * 1993-06-04 1995-01-03 Demeter Biotechnologies, Ltd. Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
WO1995013085A1 (en) * 1993-11-08 1995-05-18 Demeter Biotechnologies Ltd. Methylated lysine-rich lytic peptides and method of making same by reductive alkylation
US5789542A (en) 1994-04-22 1998-08-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Amphipathic peptides
IL114697A0 (en) 1994-07-22 1995-11-27 Demeter Biotech Ltd Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use
AU1072897A (en) * 1995-12-12 1997-07-03 Karolinska Innovations Ab Peptide binding the klvff-sequence of amyloid beta
US6566334B1 (en) * 1997-02-06 2003-05-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Short amphipathic peptides with activity against bacteria and intracellular pathogens
US6635740B1 (en) * 1997-03-27 2003-10-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Ligand/lytic peptide compositions and methods of use
US6958212B1 (en) * 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
MXPA02006752A (es) 2000-01-06 2004-09-10 Monsanto Technology Llc Preparacion de proteinas y permutenias desalergenizadas.

Similar Documents

Publication Publication Date Title
JP2009137992A5 (cg-RX-API-DMAC7.html)
UA106756C2 (uk) Генетичні маркери, асоційовані з відповіддю на інтерферон-альфа
DE602006012469D1 (de) Bipolare medizinische elektrodenanordnung mit kanüle und entfernbarer anschlusselektrode
WO2007143098A3 (en) Hepatocyte growth factor (hgf) binding proteins
EP2361934A3 (en) Hepatocyte growth factor (HGF) binding proteins
NZ603200A (en) Peptides and their use
SI2176252T1 (sl) 2,3-dihidrobenzo(1,4)dioksin-2-ilmetilni derivati kot alfa2C antagonisti za uporabo v zdravljenju bolezni perifernega in centralnega živčnega sistema
MX2010002296A (es) Inhibidores iv de polimerasa de fosfadiazina hcv.
ATE525070T1 (de) Silbininkomponente zur behandlung von hepatitis
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
WO2008045564A8 (en) Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
MX2010001849A (es) Depsipeptidos ciclicos.
MY148723A (en) Use of pinolenic acid for the treatment of obesity
NO20065536L (no) Behandling av astma hos barn
EP1848418A4 (en) USE OF NORDIHYDROGUAIARETIC ACID DERIVATIVES FOR THE TREATMENT OF DRUG RESISTANT VIRAL AND MICROBIAL CANCERS AND INFECTIONS
EA201070195A1 (ru) ПРОИЗВОДНЫЕ 1,2,3,4-ТЕТРАГИДРОПИРРОЛО [1,2-А]ПИРАЗИН-6-КАРБОКСАМИДОВ И 2,3,4,5-ТЕТРАГИДРОПИРРОЛО [1,2-a][1,4]-ДИАЗЕПИН-7-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
ZA200809686B (en) Lysobactin amindes
ITMI20050887A1 (it) Letto perfezionato elevabile e regolabile in modo da facilitare la salita e la discesa del paziente
RU2007122391A (ru) S-миртазапин для лечения приливов
ATE433459T1 (de) Desoxo-nonadepsipeptide
WO2015066664A3 (en) Compositions and methods for administration of an enzyme to a subject's airway
WO2008043570A8 (en) Interferon type i supporting compounds
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide